The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan

OBJECTIVES/HYPOTHESIS: Dupilumab, which blocks the shared receptor component for interleukin‐4 and interleukin‐13, reduced polyp size, sinus opacification, and symptom severity, and was well tolerated in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the SINUS‐52 study (NCT028984...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Laryngoscope
Huvudupphovsmän: Fujieda, Shigeharu, Matsune, Shoji, Takeno, Sachio, Asako, Mikiya, Takeuchi, Makiko, Fujita, Hiroyuki, Takahashi, Yoshinori, Amin, Nikhil, Deniz, Yamo, Rowe, Paul, Mannent, Leda
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2020
Ämnen:
Allergy, Rhinology, and Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8247406/
https://ncbi.nlm.nih.gov/pubmed/33226139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lary.29230
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk